2022 annual financial data

Sunshine Biopharma 2022 Financial results

Direct answer

Revenue was 4,345,603 USD.

Operating income was -8,674,031 USD and net income was -26,744,440 USD.
Operating cash flow was -5,248,358 USD.

Get free Sunshine Biopharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
4,345,603 USD
Operating income
-8,674,031 USD
Net income
-26,744,440 USD
Operating cash flow
-5,248,358 USD